Short answer
TG THERAPEUTICS, INC. (TGTX) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All six director nominees elected through 2027, with support ranging from 54.85% to 88.63% of votes cast.
TG THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All six director nominees elected through 2027, with support ranging from 54.85% to 88.63% of votes cast
- Sagar Lonial received the weakest director support, with 45.15% withheld votes
- KPMG LLP ratified for fiscal 2026, receiving 112,329,330 votes for versus 531,758 against
- Executive compensation advisory vote failed decisively, with 48,858,169 votes against versus 31,905,837 for
- Compensation dissent signals shareholder dissatisfaction and potential pressure on pay practices or board oversight
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TG THERAPEUTICS, INC. 8-K filings
Get the next TGTX 8-K as it lands
Follow TGTX for push alerts, or ask the research agent what this filing means.